nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenidol—Flavoxate—PDE4B—hematologic cancer	0.014	0.36	CrCbGaD
Diphenidol—Clotrimazole—ABCC3—hematologic cancer	0.00977	0.252	CrCbGaD
Diphenidol—Biperiden—ABCB1—hematologic cancer	0.00422	0.109	CrCbGaD
Diphenidol—Fexofenadine—ABCB1—hematologic cancer	0.00256	0.0659	CrCbGaD
Diphenidol—Clotrimazole—ABCB1—hematologic cancer	0.00198	0.0509	CrCbGaD
Diphenidol—Bepridil—ABCB1—hematologic cancer	0.00184	0.0473	CrCbGaD
Diphenidol—Fentanyl—ABCB1—hematologic cancer	0.00169	0.0435	CrCbGaD
Diphenidol—Loperamide—ABCB1—hematologic cancer	0.00163	0.0419	CrCbGaD
Diphenidol—Methadone—ABCB1—hematologic cancer	0.00116	0.0298	CrCbGaD
Diphenidol—CHRM3—Signaling Pathways—PDGFA—hematologic cancer	0.000234	0.000243	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—MAP2K1—hematologic cancer	0.000233	0.000243	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—GRB2—hematologic cancer	0.000232	0.000241	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—PIK3CD—hematologic cancer	0.000232	0.000241	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PDGFA—hematologic cancer	0.000231	0.000241	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—KITLG—hematologic cancer	0.000231	0.00024	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—KITLG—hematologic cancer	0.00023	0.00024	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—KITLG—hematologic cancer	0.000228	0.000237	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—STAT5A—hematologic cancer	0.000226	0.000235	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—PIK3CB—hematologic cancer	0.000225	0.000234	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—STAT5A—hematologic cancer	0.000225	0.000234	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—PIK3CB—hematologic cancer	0.000224	0.000234	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CDKN2B—hematologic cancer	0.000224	0.000233	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—MTHFR—hematologic cancer	0.000224	0.000233	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CDKN2B—hematologic cancer	0.000223	0.000232	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—STAT5A—hematologic cancer	0.000223	0.000232	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—PIK3CB—hematologic cancer	0.000222	0.000231	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—PIK3R1—hematologic cancer	0.000222	0.00023	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CDKN2B—hematologic cancer	0.000221	0.00023	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—PIK3R1—hematologic cancer	0.000221	0.00023	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—PIK3R1—hematologic cancer	0.000219	0.000228	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CD86—hematologic cancer	0.000217	0.000225	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CD86—hematologic cancer	0.000216	0.000225	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—JAK2—hematologic cancer	0.000215	0.000224	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—JAK2—hematologic cancer	0.000215	0.000223	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CD86—hematologic cancer	0.000214	0.000222	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—HES1—hematologic cancer	0.000214	0.000222	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—HES1—hematologic cancer	0.000213	0.000221	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—JAK2—hematologic cancer	0.000213	0.000221	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—NCOR1—hematologic cancer	0.000212	0.000221	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—NCOR1—hematologic cancer	0.000212	0.00022	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—HES1—hematologic cancer	0.000211	0.000219	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CSF2—hematologic cancer	0.00021	0.000218	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—FGF1—hematologic cancer	0.00021	0.000218	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—NCOR1—hematologic cancer	0.00021	0.000218	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CSF2—hematologic cancer	0.000209	0.000218	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—FGF1—hematologic cancer	0.000209	0.000218	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CSF2—hematologic cancer	0.000207	0.000216	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—FGF1—hematologic cancer	0.000207	0.000216	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—FOXO1—hematologic cancer	0.000207	0.000215	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—IL2—hematologic cancer	0.000207	0.000215	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PDGFRB—hematologic cancer	0.000207	0.000215	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—FOXO1—hematologic cancer	0.000206	0.000215	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—IL2—hematologic cancer	0.000206	0.000214	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PDGFRB—hematologic cancer	0.000206	0.000214	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—PIK3CB—hematologic cancer	0.000205	0.000213	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—FOXO1—hematologic cancer	0.000204	0.000213	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—IL2—hematologic cancer	0.000204	0.000212	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PDGFRB—hematologic cancer	0.000204	0.000212	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—PIK3CB—hematologic cancer	0.000204	0.000212	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PDGFRA—hematologic cancer	0.000203	0.000212	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PDGFRA—hematologic cancer	0.000203	0.000211	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—JAK1—hematologic cancer	0.000203	0.000211	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PRKCG—hematologic cancer	0.000203	0.000211	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PRKCG—hematologic cancer	0.000202	0.00021	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—JAK1—hematologic cancer	0.000202	0.00021	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—PIK3CB—hematologic cancer	0.000202	0.00021	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PDGFRA—hematologic cancer	0.000201	0.000209	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PRKCG—hematologic cancer	0.0002	0.000208	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—JAK1—hematologic cancer	0.0002	0.000208	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—IL2RA—hematologic cancer	0.000189	0.000197	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—IL2RA—hematologic cancer	0.000189	0.000196	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PIK3CG—hematologic cancer	0.000188	0.000196	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—IL2—hematologic cancer	0.000188	0.000195	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—IL2—hematologic cancer	0.000187	0.000195	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—TERT—hematologic cancer	0.000187	0.000195	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—IL2RA—hematologic cancer	0.000187	0.000194	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—TERT—hematologic cancer	0.000187	0.000194	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—IL2—hematologic cancer	0.000185	0.000193	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—TERT—hematologic cancer	0.000185	0.000192	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PDGFB—hematologic cancer	0.000183	0.00019	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PDGFB—hematologic cancer	0.000182	0.000189	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PDGFB—hematologic cancer	0.00018	0.000188	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—TSC2—hematologic cancer	0.000179	0.000186	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—TSC2—hematologic cancer	0.000178	0.000185	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—TSC2—hematologic cancer	0.000176	0.000183	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—CREBBP—hematologic cancer	0.000174	0.000181	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—FGFR3—hematologic cancer	0.000172	0.000179	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—FGFR3—hematologic cancer	0.000171	0.000178	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—MAPK14—hematologic cancer	0.00017	0.000177	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—FGFR3—hematologic cancer	0.00017	0.000176	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—MAPK14—hematologic cancer	0.000169	0.000176	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MAPK14—hematologic cancer	0.000168	0.000175	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—ESR1—hematologic cancer	0.000167	0.000174	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—ESR1—hematologic cancer	0.000166	0.000173	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PIK3CD—hematologic cancer	0.000165	0.000172	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—FN1—hematologic cancer	0.000165	0.000171	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—ESR1—hematologic cancer	0.000165	0.000171	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—FN1—hematologic cancer	0.000164	0.000171	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—ALB—hematologic cancer	0.000163	0.00017	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—NFKBIA—hematologic cancer	0.000163	0.000169	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—BAD—hematologic cancer	0.000163	0.000169	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—FN1—hematologic cancer	0.000163	0.000169	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—BAD—hematologic cancer	0.000162	0.000169	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—NFKBIA—hematologic cancer	0.000162	0.000169	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—NOTCH1—hematologic cancer	0.000161	0.000168	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—NOTCH1—hematologic cancer	0.000161	0.000167	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—BAD—hematologic cancer	0.000161	0.000167	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—NFKBIA—hematologic cancer	0.000161	0.000167	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—NOTCH1—hematologic cancer	0.000159	0.000166	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CD80—hematologic cancer	0.000158	0.000164	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PIK3CG—hematologic cancer	0.000158	0.000164	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—KIT—hematologic cancer	0.000158	0.000164	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—NRAS—hematologic cancer	0.000158	0.000164	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CD80—hematologic cancer	0.000157	0.000164	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PIK3CG—hematologic cancer	0.000157	0.000164	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—KIT—hematologic cancer	0.000157	0.000164	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—NRAS—hematologic cancer	0.000157	0.000164	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PIK3R1—hematologic cancer	0.000156	0.000162	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CD80—hematologic cancer	0.000156	0.000162	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PIK3CG—hematologic cancer	0.000156	0.000162	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—KIT—hematologic cancer	0.000156	0.000162	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—NRAS—hematologic cancer	0.000156	0.000162	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PTPN11—hematologic cancer	0.000155	0.000161	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PTPN11—hematologic cancer	0.000154	0.000161	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PTPN11—hematologic cancer	0.000153	0.000159	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—MAPK3—hematologic cancer	0.000151	0.000157	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—MAPK3—hematologic cancer	0.000151	0.000157	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CREB1—hematologic cancer	0.00015	0.000156	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CREB1—hematologic cancer	0.00015	0.000156	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—MAPK3—hematologic cancer	0.000149	0.000155	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—BRAF—hematologic cancer	0.000148	0.000154	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CREB1—hematologic cancer	0.000148	0.000154	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—BRAF—hematologic cancer	0.000148	0.000154	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CCL2—hematologic cancer	0.000147	0.000153	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—IL6R—hematologic cancer	0.000146	0.000152	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CCL2—hematologic cancer	0.000146	0.000152	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—BRAF—hematologic cancer	0.000146	0.000152	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CREBBP—hematologic cancer	0.000146	0.000152	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—IL6R—hematologic cancer	0.000146	0.000152	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CREBBP—hematologic cancer	0.000146	0.000152	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CCL2—hematologic cancer	0.000145	0.000151	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—IL6R—hematologic cancer	0.000145	0.00015	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CREBBP—hematologic cancer	0.000144	0.00015	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PIK3CB—hematologic cancer	0.000144	0.00015	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—MAP2K1—hematologic cancer	0.00014	0.000145	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—MAP2K1—hematologic cancer	0.000139	0.000145	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PIK3CD—hematologic cancer	0.000139	0.000144	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PIK3CD—hematologic cancer	0.000138	0.000144	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MAP2K1—hematologic cancer	0.000138	0.000143	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	0.000137	0.000143	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—PIK3CA—hematologic cancer	0.000137	0.000142	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PIK3CD—hematologic cancer	0.000137	0.000142	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—KRAS—hematologic cancer	0.000136	0.000141	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—PIK3CA—hematologic cancer	0.000136	0.000141	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—KRAS—hematologic cancer	0.000135	0.000141	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—KRAS—hematologic cancer	0.000134	0.000139	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—FGF2—hematologic cancer	0.000133	0.000138	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—FGF2—hematologic cancer	0.000132	0.000138	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—FGF2—hematologic cancer	0.000131	0.000136	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PIK3R1—hematologic cancer	0.000131	0.000136	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PIK3R1—hematologic cancer	0.00013	0.000136	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PIK3R1—hematologic cancer	0.000129	0.000134	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—JAK2—hematologic cancer	0.000127	0.000132	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—JAK2—hematologic cancer	0.000127	0.000132	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—JAK2—hematologic cancer	0.000126	0.000131	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—PIK3CA—hematologic cancer	0.000125	0.00013	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PTEN—hematologic cancer	0.000124	0.000129	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—PIK3CA—hematologic cancer	0.000124	0.000129	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—MDM2—hematologic cancer	0.000124	0.000129	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—MDM2—hematologic cancer	0.000124	0.000129	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—PIK3CA—hematologic cancer	0.000123	0.000128	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MDM2—hematologic cancer	0.000123	0.000128	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—MTOR—hematologic cancer	0.000121	0.000126	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PIK3CB—hematologic cancer	0.000121	0.000126	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—MTOR—hematologic cancer	0.00012	0.000125	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PIK3CB—hematologic cancer	0.00012	0.000125	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PIK3CB—hematologic cancer	0.000119	0.000124	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MTOR—hematologic cancer	0.000119	0.000124	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—EP300—hematologic cancer	0.000119	0.000123	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—HRAS—hematologic cancer	0.000115	0.00012	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—HRAS—hematologic cancer	0.000115	0.00012	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—HRAS—hematologic cancer	0.000114	0.000118	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CDKN1B—hematologic cancer	0.000113	0.000118	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CDKN1B—hematologic cancer	0.000113	0.000118	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—AKT1—hematologic cancer	0.000112	0.000117	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CDKN1B—hematologic cancer	0.000112	0.000116	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—AKT1—hematologic cancer	0.000112	0.000116	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CASP3—hematologic cancer	0.000111	0.000116	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—IL2—hematologic cancer	0.000111	0.000115	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CASP3—hematologic cancer	0.000111	0.000115	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—AKT1—hematologic cancer	0.000111	0.000115	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—IL2—hematologic cancer	0.000111	0.000115	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—IL6—hematologic cancer	0.00011	0.000115	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—IL6—hematologic cancer	0.00011	0.000114	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CASP3—hematologic cancer	0.00011	0.000114	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—IL2—hematologic cancer	0.00011	0.000114	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—IL6—hematologic cancer	0.000109	0.000113	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CCND1—hematologic cancer	0.000108	0.000113	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—JUN—hematologic cancer	0.000108	0.000112	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CCND1—hematologic cancer	0.000108	0.000112	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—JUN—hematologic cancer	0.000108	0.000112	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CCND1—hematologic cancer	0.000107	0.000111	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—JUN—hematologic cancer	0.000107	0.000111	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CDKN1A—hematologic cancer	0.000105	0.000109	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PTEN—hematologic cancer	0.000104	0.000109	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CDKN1A—hematologic cancer	0.000104	0.000109	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PTEN—hematologic cancer	0.000104	0.000108	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	0.000103	0.000107	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PTEN—hematologic cancer	0.000103	0.000107	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—MAPK8—hematologic cancer	0.000102	0.000106	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—AKT1—hematologic cancer	0.000102	0.000106	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—MAPK8—hematologic cancer	0.000102	0.000106	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—AKT1—hematologic cancer	0.000102	0.000106	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	0.000101	0.000105	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	0.000101	0.000105	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—EP300—hematologic cancer	9.96e-05	0.000104	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—EP300—hematologic cancer	9.92e-05	0.000103	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—EP300—hematologic cancer	9.83e-05	0.000102	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—SRC—hematologic cancer	9.68e-05	0.000101	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—SRC—hematologic cancer	9.65e-05	0.0001	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—SRC—hematologic cancer	9.56e-05	9.94e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—VEGFA—hematologic cancer	9.43e-05	9.81e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—VEGFA—hematologic cancer	9.4e-05	9.78e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—STAT3—hematologic cancer	9.34e-05	9.71e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—NRAS—hematologic cancer	9.31e-05	9.69e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	9.31e-05	9.68e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—STAT3—hematologic cancer	9.31e-05	9.68e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—NRAS—hematologic cancer	9.28e-05	9.66e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—STAT3—hematologic cancer	9.22e-05	9.59e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—NRAS—hematologic cancer	9.19e-05	9.56e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—MAPK3—hematologic cancer	8.92e-05	9.28e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—MAPK3—hematologic cancer	8.89e-05	9.25e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	8.8e-05	9.16e-05	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PIK3CA—hematologic cancer	8.78e-05	9.13e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—MYC—hematologic cancer	8.68e-05	9.03e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—TGFB1—hematologic cancer	8.65e-05	9e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—MYC—hematologic cancer	8.65e-05	9e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—TGFB1—hematologic cancer	8.63e-05	8.98e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MYC—hematologic cancer	8.56e-05	8.91e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	8.54e-05	8.89e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—KRAS—hematologic cancer	8.02e-05	8.34e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—KRAS—hematologic cancer	7.99e-05	8.31e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—KRAS—hematologic cancer	7.91e-05	8.23e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PIK3CA—hematologic cancer	7.36e-05	7.66e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PIK3CA—hematologic cancer	7.34e-05	7.64e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	7.27e-05	7.56e-05	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—AKT1—hematologic cancer	7.17e-05	7.46e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—TP53—hematologic cancer	7.12e-05	7.41e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—TP53—hematologic cancer	7.1e-05	7.39e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—TP53—hematologic cancer	7.03e-05	7.32e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—HRAS—hematologic cancer	6.81e-05	7.09e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—HRAS—hematologic cancer	6.79e-05	7.07e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—HRAS—hematologic cancer	6.73e-05	7e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—IL6—hematologic cancer	6.52e-05	6.78e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—IL6—hematologic cancer	6.5e-05	6.76e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—IL6—hematologic cancer	6.44e-05	6.7e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—AKT1—hematologic cancer	6.02e-05	6.26e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—AKT1—hematologic cancer	6e-05	6.24e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—AKT1—hematologic cancer	5.94e-05	6.18e-05	CbGpPWpGaD
